CNTB vs. CTMX
CNTB (Connect Biopharma Holdings Limited) and CTMX (CytomX Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.28 correlation means their historical movements had little consistent relationship.
Performance
CNTB vs. CTMX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CNTB achieves a -30.14% return, which is significantly lower than CTMX's -25.59% return.
CNTB
- 1D
- -2.48%
- 1M
- -19.92%
- 6M
- -19.92%
- YTD
- -30.14%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
CTMX
- 1D
- 2.26%
- 1M
- -17.02%
- 6M
- -47.95%
- YTD
- -25.59%
- 1Y
- 34.89%
- 3Y*
- 23.33%
- 5Y*
- -10.69%
- 10Y*
- -11.99%
- ALL TIME*
- -13.90%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $452.87K | $1.14M | $870.47K | |
| $8.52M | $11.43M | $14.43M |
CNTB vs. CTMX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CNTB Connect Biopharma Holdings Limited | -30.14% | 28.18% |
CTMX CytomX Therapeutics, Inc. | -25.59% | 104.81% |
Correlation
The correlation between CNTB and CTMX is 0.28, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 3, 2025 | 0.28 |
Fundamentals
CNTB:
$124.04M
CTMX:
$509.81M
CNTB:
-$1.28
CTMX:
-$0.35
CNTB:
4.21
CTMX:
15.24
CNTB:
2.61
CTMX:
1.76
CNTB:
$26.03M
CTMX:
$35.54M
CNTB:
$25.37M
CTMX:
$24.77M
CNTB:
-$72.75M
CTMX:
-$62.07M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNTB vs. CTMX — Risk / Return Rank
CNTB
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CTMX
CNTB vs. CTMX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Connect Biopharma Holdings Limited (CNTB) and CytomX Therapeutics, Inc. (CTMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CNTB | CTMX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.17 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 0.62 | — |
| Martin ratioReturn relative to average drawdown | — | 1.23 | — |
Loading charts...
Drawdowns
CNTB vs. CTMX - Drawdown Comparison
The maximum CNTB drawdown since its inception was -46.61%, smaller than the maximum CTMX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for CNTB and CTMX.
Loading charts...
Drawdown Indicators
| CNTB | CTMX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.61% | -98.74% | +52.13% |
Max Drawdown (1Y)Largest decline over 1 year | — | -56.89% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -91.59% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -94.16% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.74% | — |
Current DrawdownCurrent decline from peak | -46.61% | -90.74% | +44.13% |
Average DrawdownAverage peak-to-trough decline | -25.66% | -71.13% | +45.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 28.40% | — |
Volatility
CNTB vs. CTMX - Volatility Comparison
Loading charts...
Volatility by Period
| CNTB | CTMX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 10.67% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 62.14% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 93.07% | 93.60% | -0.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 93.07% | 141.99% | -48.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.07% | 111.41% | -18.34% |
Dividends
CNTB vs. CTMX - Dividend Comparison
Neither CNTB nor CTMX has paid dividends to shareholders.
Financials
CNTB vs. CTMX - Financials Comparison
This section allows you to compare key financial metrics between Connect Biopharma Holdings Limited and CytomX Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CNTB and CTMX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CNTB and CTMX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer